Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 27 Show results per page	View Search Criteria \| Help With Results


1.		Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 to 70				Pharmaceutical / Industry				EGF102988 NCT00424255


2.		Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				Not specified				Other				7077 NCT00140556


3.		Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				Over 18				Pharmaceutical / Industry				UCIRB #14735B GV-001.010 (TNF-ELF), NCT00496236

Last Modified: 10/21/2008 First Published: 6/23/2003


4.		Phase II Randomized Study of Fruit and Vegetable Extracts in Patients With Stage I-IVB Head and Neck Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				CCCWFU-0112 CCCWFU-60A02, CCCWFU-BG03-161, NCT00064298

Last Modified: 10/16/2008 First Published: 10/25/2004


5.		Phase II Randomized Study of Concurrent Radiotherapy and Chemotherapy Comprising Carboplatin and Paclitaxel With Versus Without Amifostine in Patients With Newly Diagnosed Stage II, III, or IV Squamous Cell Carcinoma of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				DFCI-03018 NCT00095927


6.		A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				12652A NCT00203905


7.		Use of Cone Beam Kilovaltage Imaging in Patients Receiving Radiation Therapy for Head and Neck Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				06U.195 NCT00358007

Last Modified: 7/15/2008 First Published: 1/5/2007


8.		Phase II Study of Chemoradiotherapy Comprising Cisplatin, Bevacizumab, and Intensity-Modulated Radiotherapy in Patients With Stage III or IV Squamous Cell Carcinoma of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI, Pharmaceutical / Industry				MSKCC-06130 PFIZER-MSKCC-06130, NCT00423930


9.		Sorafenib Plus Carboplatin and Paclitaxel in Head and Neck Squamous Cell Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				2006-0940 NCT00494182

Last Modified: 5/22/2008 First Published: 11/29/2007


10.		Phase II Study of Intensification Therapy Comprising Cisplatin and Paclitaxel in Combination With Radiotherapy and Surgery in Patients With Resectable Advanced Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, or Hypopharynx

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				Over 18				NCI				OSU-06026 OSU 06026, OSU-2007C0056, NCT00566540

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute